๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thyroid-Associated Ophthalmopathy

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease NCT07262476Phase 31 site๐Ÿ“ Shanghai Minghui Pharmaceutical (Hangzhou) Ltd ยท Tests: MHB018A injection Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy NCT06590220n/a1 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital Systemic Inflammation, Thyroid Autoimmunity and Neuroretinal Changes in Graves Disease NCT07480720n/a1 site๐Ÿ“ ElรขzฤฑฤŸ Elazฤฑg Fethi Sekin Sehir Hastanesi Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease NCT06081439n/a1 site๐Ÿ“ Gothenburg Vastra Gotaland Region Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease NCT07547930Phase 21 site๐Ÿ“ Xiamen The First Affiliated Hospital of Xiamen University ยท Tests: Tofacitinib Bimatoprost as a Treatment for Graves' Orbitopathy NCT03708627EARLY Phase 11 site๐Ÿ“ Seattle Johns Hopkins University ยท Tests: Bimatoprost Ophthalmic Evaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease NCT07885605Phase 13 sites๐Ÿ“ Orland Park๐Ÿ“ Las Vegas๐Ÿ“ Wilmington Ethyreal Bio, Inc. ยท Tests: ETHY-001, Placebo Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease NCT07400757NA1 site๐Ÿ“ Taipei Taipei Veterans General Hospital, Taiwan ยท Tests: Atorvastatin (Lipitor), Vitamin D Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment. NCT07152366Phase 41 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: IBI311, Glucocorticoids A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease NCT07265258Phase 41 site๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: Teprotumumab N01, Methylprednisolone Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment NCT07117981n/a9 sites๐Ÿ“ Paris๐Ÿ“ Caen๐Ÿ“ Lyon Centre Hospitalier National d'Ophtalmologie des Quinze-Vingโ€ฆ Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease NCT04936854Phase 21 site๐Ÿ“ Bergen Haukeland University Hospital ยท Tests: Sirolimus 1 mg Oral Tablet, Methylprednisolone A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye Disease NCT07113262Phase 31 site๐Ÿ“ Shenyang Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI311, Placebo The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment. NCT07152340Phase 42 sites๐Ÿ“ Changhua๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: IBI311, Glucocorticoids Treatment of Chronic Thyroid Eye Disease With MHB018A NCT07622121Phase 31 site๐Ÿ“ Coral Gables Minghui Pharmaceutical (Hangzhou) Ltd ยท Tests: MHB018A injection, MHB018A injection Placebo An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease NCT07438405Phase 28 sites๐Ÿ“ Little Rock๐Ÿ“ Kissimmee๐Ÿ“ Orland Park Amgen ยท Tests: AMG 732 Early Risk Stratification of Thyroid Eye Disease in Newly Diagnosed Graves' Disease NCT07812194n/a1 site๐Ÿ“ Herlev University of Copenhagen ยท Tests: Study-related ophthalmological assessment and biospecimen collection, Blood biomarkers and standardized blood samples iโ€ฆ Orbital Radiotherapy in Grave's Ophthalmopathy 1 Week vs 2 Weeks (OraGO-1 Trial) NCT06392906Phase 31 site๐Ÿ“ Bangkok Noi Janjira Petsuksiri ยท Tests: Short course radiation therapy, Standard course radiation therapy A Study of IBI3031 in Participants With Thyroid Eye Disease NCT07622368Phase 11 site๐Ÿ“ Shenyang Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI3031, placebo Treatment of Gravesยดophthalmopathy with Simvastatin (GO-S) NCT03131726Phase 31 site๐Ÿ“ Malmรถ Lund University ยท Tests: Simvastatin 40mg Comparative Evaluation of 68Ga-FAPI and 68Ga-DOTATATE PET/CT and PET/MRI in Thyroid Eye Disease NCT07835607n/a1 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: 68Ga-FAPI PET/CT and PET/MR Imaging, 68Ga-DOTATATE PET/CT and PET/MR Imaging A Clinical Study of Cizutamig in Thyroid Eye Disease NCT07597200Phase 114 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Fuzhou Candid Therapeutics ยท Tests: Cizutamig will be dosed according to the protocol. Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting NCT05012033n/a1 site๐Ÿ“ London Imperial College London ยท Tests: No intervention - prednisolone is taken as part if routine clinical care. Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED) NCT07753603Phase 318 sites๐Ÿ“ Glendale๐Ÿ“ Beverly Hills๐Ÿ“ Canoga Park Sling Therapeutics, Inc. ยท Tests: linsitinib, Placebo Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) NCT06112340Phase 2, Phase 32 sites๐Ÿ“ Miami๐Ÿ“ Morgantown Sling Therapeutics, Inc. ยท Tests: linsitinib Hydroxychloroquine in Mild Graves' Orbitopathy NCT05126147Phase 42 sites๐Ÿ“ Hsinchu๐Ÿ“ Taipei National Taiwan University Hospital ยท Tests: Hydroxychloroquine Screening, Classification, and Outcome Prediction Ensemble Using Orbital MRI for Thyroid Eye Disease: The TED SCOPE National Multicenter Registry Study NCT07716397n/a1 site๐Ÿ“ Shanghai Shanghai Changzheng Hospital ยท Tests: MRI scan๏ผŒocular ultrasound Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease. NCT07423013NA1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: [18F]AlF-NOTA-FAPI-04PET/CT, 5.0-T high-resolution MRI Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease NCT06359795NA1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: 18F-AlF-FAPI PET/CT, 99mTc-DTPA SPECT/CT
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy